new warnings for patients taking Cylert (pemoline)

You'll see new warnings for patients taking Cylert (pemoline).

Abbott now recommends that patients sign a consent form before starting Cylert...and get liver function tests EVERY TWO WEEKS.

Cylert is no longer recommended for initial therapy of attention deficit disorder...due to the risk of hepatotoxicity.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote